Latest news
Genmab A/S (GMAB) raises 2026 outlook on DARZALEX and EPKINLY growth - Stock TitanStock Titan · Thu, 06 Aug 2026 15:09:23 GMTGilead’s HIV PrEP franchise hits $1B quarterly sales, but analysts question Yeztugo durability - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 14:44:51 GMTFor the first time, Gilead's HIV prevention franchise crosses $1B in quarterly sales - FirstWord PharmaFirstWord Pharma · Wed, 05 Aug 2026 13:56:57 GMTGilead Raised HIV Guidance on Its Q2 Earnings Call. Here’s What That Means for GILD Stock. - TIKR.comTIKR.com · Wed, 05 Aug 2026 10:39:48 GMTGilead Revenue Jumps as Acquisitions Lead to Adjusted Loss - Barron'sBarron's · Tue, 04 Aug 2026 21:08:00 GMTStock Market Today: Live Updates 03.08.2026 - TechStock²TechStock² · Mon, 03 Aug 2026 08:00:02 GMT